性猛交XXXX乱大交派对,四虎影视WWW在线观看免费 ,137最大但人文艺术摄影,联系附近成熟妇女

深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司
中級(jí)會(huì)員 | 第9年

15012456311

替格瑞洛雜質(zhì)對(duì)照品

參   考   價(jià): 100

訂  貨  量: ≥1 

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號(hào)

品       牌其他品牌

廠商性質(zhì)生產(chǎn)商

所  在  地深圳市

更新時(shí)間:2016-04-29 16:36:09瀏覽次數(shù):1485次

聯(lián)系我時(shí),請(qǐng)告知來(lái)自 化工儀器網(wǎng)
同類優(yōu)質(zhì)產(chǎn)品更多>
替格瑞洛雜質(zhì)對(duì)照品
提供NMR,HPLC,MS圖譜及COA證書,新藥申報(bào)可用
Ticagrelor Impurity
全部雜質(zhì)現(xiàn)貨供應(yīng),*,并可接受定制。

替格瑞洛雜質(zhì)對(duì)照品   產(chǎn)品介紹:
規(guī)格:10mg/25mg/50mg/100mg等多種規(guī)格可選。
用途:實(shí)驗(yàn)研發(fā),藥品申報(bào)檢測(cè),不得用于臨床醫(yī)學(xué)診斷。
隨貨提供:所有雜質(zhì)對(duì)照品均隨貨提供HPLC,NMR,MS圖譜及CoA證書。

 

國(guó)產(chǎn)進(jìn)口品牌皆有銷售,產(chǎn)品庫(kù)時(shí)常會(huì)有更新,另外,我司有專業(yè)研發(fā)團(tuán)隊(duì),可提供部分雜質(zhì)定制服務(wù),以zui大可能的滿足您雜質(zhì)對(duì)照品的選購(gòu)需求。

 

替格瑞洛雜質(zhì)對(duì)照品    雜質(zhì)列表:

Ticagrelor(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 1(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 2(1S,2S,3R,5S)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 3(1R,2R,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 4(Mixture of Diastereomers)(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1)
Ticagrelor Impurity 5(Mixture of Diastereomers)(1R,2R,3S,5R)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1R,2R,3S,5R)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1)
Ticagrelor Impurity 62-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
Ticagrelor Impurity 7(1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 8(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 92-(((3aR,4S,6R,6aS)-6-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
Ticagrelor Impurity 105-amino-6-chloro-2-(propylthio)pyrimidin-4-ol
Ticagrelor Impurity 112-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)oxy)ethanol
Ticagrelor Impurity 12(1S,2S,3R,5S)-3-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 135-amino-6-(((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)amino)-2-(propylthio)pyrimidin-4-ol
Ticagrelor Impurity 14(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 15(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-methoxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 162-(((3aS,4R,6S,6aR)-6-((3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol
Ticagrelor Impurity 17(1R,2R,3S,5R)-3-((3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 18(1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 19(1S,2S,3R,5S)-3-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 20(1S,2R,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol
Ticagrelor Impurity 21(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 22(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 23sodium 7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-olate
Ticagrelor Impurity 24(1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 25(1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 262-((6-chloro-5-(7-(2-hydroxyethoxy)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2-(propylthio)pyrimidin-4-yl)oxy)ethanol
Ticagrelor Impurity 27(1S,2S,3S,5R)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Ticagrelor Impurity 287-chloro-3-(4,6-dichloro-2-(propylthio)pyrimidin-5-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidine
Ticagrelor Impurity 29(1S,2S,3R,5S)-3-(2-hydroxyethoxy)-5-(5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2-diol
Ticagrelor Impurity 302-(((3aR,4R,6S,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol

 

   除自主雜質(zhì)對(duì)照品品牌外,我司優(yōu)勢(shì)代理多個(gè)進(jìn)口雜質(zhì)品牌:EP,USP,JP,LGC,TRC,TLC,Molcan等,*滿足您對(duì)雜質(zhì)對(duì)照品的需求。另代理意大利Chromogenix肝素檢測(cè)試劑,英國(guó)NIBSC標(biāo)準(zhǔn)試劑,Sigma-Aldrich試劑, 美國(guó)ChromaDex中草藥標(biāo)準(zhǔn)品,瑞士CaroteNature類胡蘿卜素標(biāo)準(zhǔn)品,法國(guó)Extrasynthese中草藥標(biāo)準(zhǔn)品,WHO世界衛(wèi)生組織藥物標(biāo)準(zhǔn)品,NIST美國(guó)國(guó)家標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品,IRRM歐洲標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品等各種標(biāo)準(zhǔn)品,CIL美國(guó)劍橋同位素標(biāo)準(zhǔn)品,種類齊全,到貨迅速。

 

     英國(guó)NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表:

10/175               Reteplase Reference Material

13/322               Polio Anti Sabin type 105 (inactivated) Serum

95/596               Interleukin-57 (Human, rDNA derived)

01/509               Meningococcal serogroup W polysaccharide

13/239               Polio Anti Sabin type 22 (inactivated) Serum

07/300               BCG Vaccine of Russian BCG-I sub-strain(27st WHO Reference Reagent)

13/249               C-Peptide, Human. 104st International Standard.

95/571               Interleukin-32 (Human, rDNA derived)

95/602               Interleukin-63 (Human, rDNA derived)

10/173               Reteplase Reference Material

10/127               Reteplase Reference Material

01/461               Meningococcal serogroup W polysaccharide

13/294               Polio Anti Sabin type 77 (inactivated) Serum

13/233               C-Peptide, Human. 88st International Standard.

95/572               Interleukin-33 (Human, rDNA derived)

03/104-079         HTLV-64 (antibody) Monitor Sample

13/144               Influenza Antigen B/Massachusetts/02/2022 (Egg derived)

13/180               Influenza Antigen B/Massachusetts/02/2058 (Egg derived)

01/528               Meningococcal serogroup W polysaccharide

13/178               C-Peptide, Human. 33st International Standard.

07/373               BCG Vaccine of Russian BCG-I sub-strain(100st WHO Reference Reagent)

07/324               BCG Vaccine of Russian BCG-I sub-strain(51st WHO Reference Reagent)

13/241               C-Peptide, Human. 96st International Standard.

07/290               BCG Vaccine of Russian BCG-I sub-strain(17st WHO Reference Reagent)

03/104-061         HTLV-46 (antibody) Monitor Sample

07/358               BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent)

10/185               Reteplase Reference Material

07/364               BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent)

03/104-056         HTLV-41 (antibody) Monitor Sample

13/146               C-Peptide, Human. 1st International Standard.

12/B623-083       QCRFLUAH1N1QC1-Influenza AH1N1 QC81

10/158               Reteplase Reference Material

13/229               C-Peptide, Human. 84st International Standard.

01/428               Meningococcal serogroup W polysaccharide

01/449               Meningococcal serogroup W polysaccharide

13/236               Influenza Antigen B/Massachusetts/02/2114 (Egg derived)

13/233               Influenza Antigen B/Massachusetts/02/2111 (Egg derived)

07/359               BCG Vaccine of Russian BCG-I sub-strain(86st WHO Reference Reagent)

 

更多關(guān)于    的產(chǎn)品信息,請(qǐng)我司。

會(huì)員登錄

×

請(qǐng)輸入賬號(hào)

請(qǐng)輸入密碼

=

請(qǐng)輸驗(yàn)證碼

收藏該商鋪

X
該信息已收藏!
標(biāo)簽:
保存成功

(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

常用:

提示

X
您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
撥打電話
在線留言
武强县| 皋兰县| 宣威市| 固镇县| 襄城县| 和硕县| 凤冈县| 娄底市| 靖西县| 周口市| 当涂县| 西藏| 辰溪县| 睢宁县| 利辛县| 台中县| 莱芜市| 宜兰市| 隆昌县| 长春市| 蒙自县| 巴彦县| 桂阳县| 米林县| 右玉县| 孟津县| 图木舒克市| 广丰县| 韶山市| 纳雍县| 西安市| 湾仔区| 北宁市| 虎林市| 正阳县| 岳阳县| 永嘉县| 新沂市| 灌云县| 博湖县| 鹤峰县|